Rader: “The law makes no sense any more”

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Rader: “The law makes no sense any more”

Former Chief Judge of the Federal Circuit Randall Rader has said that recent Supreme Court decisions have left the United States so out of step with the rest of the world that legislative correction is needed

randall20rader20aipla.jpg

“The point is the law makes no sense any more, and when it makes no sense any more it has to be rewritten,” Rader said in an afternoon session on patent law yesterday at the AIPLA Annual Meeting. “Not in the House, but the Senate – the Republicans are coming!”

Rader said that he recently did something he had not done for a long time – he read a judicial opinion five times. It was the Australian Myriad judicial opinion.

“The Australian version of Myriad, not the American one, got it dead right,” said Rader. “United States law is the one that is out of tune.”

Rader appeared to suggest that the audience should consider how an appeal will affect the law before filing one. One audience member pushed him on this, saying a client may think settlement terms are unacceptable even if an appeal may change the law in a way it doesn’t like.

“What I’m telling you is if you bring Bilski to the Supreme Court you can expect the results you are going to get,” replied Rader.

“Therefore, if you are wise, you settle it before it gets there. Has that happened before? Yes. Dozens of times and that’s what this group can do strategically to get a good case so that there is good law.

“How well have you done with Bilski, Alice, Prometheus and Myriad? How do you propose we get from the US state of patent eligibility, which is out of step with the whole world, back in to harmony with international standards? I just told you – legislative correction.”

Rader said that given a case with the right characteristics, however, there is a chance for the law to be narrowed. “If you find the right case, there is room to narrow it,” he said.

bob20stoll20aipla.jpg

Responding to some pessimistic audience comments about the effect the Supreme Court is having on innovation in the technology space, Bob Stoll, the session’s moderator, said: “I do think software is patentable and claiming it in a manner that is viable is still possible. But I think there are significant problems and we need to figure out a way to make sure it doesn’t deteriorate further and does in fact get better.”

He noted that the fact that a number of industries are being affected could give cause for hope that there will be change. “I do think we have a collective pain here where we have got all the emerging technologies under attack,” said Stoll. “It is rare we get the folks in the software creation industry in complete alignment with those in the biotech industry. The catalytic manufacturing industry is also going be impacted as are surgical devices.”

He continued: “I think you’re going to find a very strong group of companies and interests looking to fix this. If we decide to go in that direction, that would be very helpful for moving things on the Hill, because I do believe that Members of Congress and Senators listen to their constituents who come to talk to them. Patent subject matter eligibility hasn’t been at the forefront in Congress, but as it elevates there may be some interest in doing something.”

more from across site and SHARED ros bottom lb

More from across our site

An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
With the London Annual Meeting behind us, we look back at some of the lessons learned this week and ahead to what 2027 will bring
Gift this article